BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 29381995)

  • 1. CXCL13 and TH1/Th2 cytokines in the serum and cerebrospinal fluid of neurosyphilis patients.
    Yan Y; Wang J; Qu B; Zhang Y; Wei Y; Liu H; Wu C
    Medicine (Baltimore); 2017 Nov; 96(47):e8850. PubMed ID: 29381995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated cerebrospinal fluid interleukin-17A and interferon-γ levels in early asymptomatic neurosyphilis.
    Pastuszczak M; Jakiela B; Wielowieyska-Szybinska D; Jaworek AK; Zeman J; Wojas-Pelc A
    Sex Transm Dis; 2013 Oct; 40(10):808-12. PubMed ID: 24275734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expressions of CXCL8, CXCL10 and Th1 /Th2 cytokines in the serum and cerebrospinal fluid of patients with neurosyphilis].
    Yu XY; Yan N; Li ZH; Chen W; Hua YH; Lu Y
    Zhonghua Nan Ke Xue; 2020 Apr; 26(4):335-340. PubMed ID: 33351301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of CXCL13 in diagnosing asymptomatic neurosyphilis in HIV-infected patients.
    Hu R; Lu C; Lu S; Hu Y; Ma H; Lai W; Zhu G; Feng P; Lu R; Li Y
    Int J STD AIDS; 2016 Feb; 27(2):141-6. PubMed ID: 25769888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CXCL13 as a cerebrospinal fluid marker for neurosyphilis in HIV-infected patients with syphilis.
    Marra CM; Tantalo LC; Sahi SK; Maxwell CL; Lukehart SA
    Sex Transm Dis; 2010 May; 37(5):283-7. PubMed ID: 20393380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CXCL13, CXCL10 and CXCL8 as Potential Biomarkers for the Diagnosis of Neurosyphilis Patients.
    Wang C; Wu K; Yu Q; Zhang S; Gao Z; Liu Y; Ni L; Cheng Y; Guan Z; Shi M; Lu H; Lou Y; Zhou P
    Sci Rep; 2016 Sep; 6():33569. PubMed ID: 27650493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic role of CXCL13 and CSF serology in patients with neurosyphilis.
    Li D; Huang X; Shi M; Luo L; Tao C
    Sex Transm Infect; 2021 Nov; 97(7):485-489. PubMed ID: 33436504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant Humoral Immune Responses in Neurosyphilis: CXCL13/CXCR5 Play a Pivotal Role for B-Cell Recruitment to the Cerebrospinal Fluid.
    Yu Q; Cheng Y; Wang Y; Wang C; Lu H; Guan Z; Huang J; Gong W; Shi M; Ni L; Wu J; Peng R; Zhou P
    J Infect Dis; 2017 Sep; 216(5):534-544. PubMed ID: 28931218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CXCL13 chemokine as a promising biomarker to diagnose neurosyphilis in HIV-negative patients.
    Zeng YL; Lin YQ; Zhang NN; Zou CN; Zhang HL; Peng F; Liu ZJ; Zheng WH; Yan JH; Liu LL
    Springerplus; 2016; 5(1):743. PubMed ID: 27376011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Has CXCL13 an added value in diagnosis of neurosyphilis?
    Mothapo KM; Verbeek MM; van der Velden LB; Ang CW; Koopmans PP; van der Ven A; Stelma F
    J Clin Microbiol; 2015 May; 53(5):1693-6. PubMed ID: 25788544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of matrix metalloproteinases and their tissue inhibitors in the serum and cerebrospinal fluid of patients with HIV-1 infection and syphilis or neurosyphilis.
    Tsai HC; Ye SY; Kunin CM; Lee SS; Wann SR; Tai MH; Shi MH; Liu YC; Chen YS
    Cytokine; 2011 May; 54(2):109-16. PubMed ID: 21354815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The chemokine CXCL13 is elevated in the cerebrospinal fluid of patients with neurosyphilis.
    Dersch R; Hottenrott T; Senel M; Lehmensiek V; Tumani H; Rauer S; Stich O
    Fluids Barriers CNS; 2015 May; 12():12. PubMed ID: 25975424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CXCL13 concentration in latent syphilis patients with treatment failure.
    Zhang Y; Wang J; Wei Y; Liu H; Wu C; Qu B; Yan Y
    Open Med (Wars); 2020; 15(1):635-643. PubMed ID: 33336020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of CXCL2 in the serum and cerebrospinal fluid of patients with HIV and syphilis or neurosyphilis.
    Tsai HC; Ye SY; Lee SS; Wann SR; Chen YS
    Inflammation; 2014 Jun; 37(3):950-5. PubMed ID: 24419746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serological Response Predicts Normalization of Cerebrospinal Fluid Abnormalities at Six Months after Treatment in HIV-Negative Neurosyphilis Patients.
    Xiao Y; Tong ML; Lin LR; Liu LL; Gao K; Chen MJ; Zhang HL; Zheng WH; Li SL; Lin HL; Lin ZF; Yang TC; Niu JJ
    Sci Rep; 2017 Aug; 7(1):9911. PubMed ID: 28855625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes of T lymphocyte subsets in patients with HIV-negative symptomatic neurosyphilis.
    Liu LL; Liu WN; Jiang XY; Jun-Ren ; Chen MH; Liu ZJ; Lin Y; Zhu SG; Lin LR; Zheng WH; Yan JH; Yang TC
    Microb Pathog; 2019 May; 130():213-218. PubMed ID: 30862559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemokine Ligand 13 (CXCL13) in Neuroborreliosis and Neurosyphilis as Selected Spirochetal Neurological Diseases: A Review of Its Diagnostic Significance.
    Gudowska-Sawczuk M; Mroczko B
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32331231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The chemokine CXCL13 is a key regulator of B cell recruitment to the cerebrospinal fluid in acute Lyme neuroborreliosis.
    Rupprecht TA; Plate A; Adam M; Wick M; Kastenbauer S; Schmidt C; Klein M; Pfister HW; Koedel U
    J Neuroinflammation; 2009 Dec; 6():42. PubMed ID: 20042073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated levels of interleukin-12 and interferon-gamma in patients with human T lymphotropic virus type I-associated myelopathy.
    Furuya T; Nakamura T; Fujimoto T; Nakane S; Kambara C; Shirabe S; Hamasaki S; Motomura M; Eguchi K
    J Neuroimmunol; 1999 Mar; 95(1-2):185-9. PubMed ID: 10229129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 1996 Moyer Award. Effects of endotoxin on the Th1/Th2 response in humans.
    Zimmer S; Pollard V; Marshall GD; Garofalo RP; Traber D; Prough D; Herndon DN
    J Burn Care Rehabil; 1996; 17(6 Pt 1):491-6. PubMed ID: 8951535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.